Wells Fargo’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
|
|||||
|
2025
Q1 | $200K | Buy |
|
|||||
|
2024
Q4 | $204K | Buy |
|
|||||
|
2024
Q3 | $137K | Buy |
|
|||||
|
2024
Q2 | $138K | Sell |
|
|||||
|
2024
Q1 | $160K | Buy |
|
|||||
|
2023
Q4 | $186K | Buy |
|
|||||
|
2023
Q3 | $129K | Sell |
|
|||||
|
2023
Q2 | $253K | Buy |
|
|||||
|
2023
Q1 | $146K | Buy |
|
|||||
|
2022
Q4 | $11.5K | Sell |
|
|||||
|
2022
Q3 | $21K | Sell |
|
|||||
|
2022
Q2 | $24K | Sell |
|
|||||
|
2022
Q1 | $71K | Sell |
|
|||||
|
2021
Q4 | $334K | Buy |
|
|||||
|
2021
Q3 | $114K | Sell |
|
|||||
|
2021
Q2 | $2.75M | Buy |
|
|||||
|
2021
Q1 | $3.73M | Sell |
|
|||||
|
2020
Q4 | $4.84M | Sell |
|
|||||
|
2020
Q3 | $4.09M | Sell |
|
|||||
|
2020
Q2 | $5.9M | Buy |
|
|||||
|
2020
Q1 | $4.62M | Buy |
|
|||||
|
2019
Q4 | $5.09M | Buy |
|
|||||
|
2019
Q3 | $3.01M | Buy |
|
|||||
|
2019
Q2 | $2.4M | Sell |
|
|||||
|
2019
Q1 | $3.41M | Buy |
|
|||||
|
2018
Q4 | $3.36M | Buy |
|
|||||
|
2018
Q3 | $4.21M | Buy |
|
|||||
|
2018
Q2 | $2.91M | Sell |
|
|||||
|
2018
Q1 | $3.31M | Buy |
|
|||||
|
2017
Q4 | $3.78M | Buy |
|
|||||
|
2017
Q3 | $4.01M | Buy |
|
|||||
|
2017
Q2 | $3.53M | Buy |
|
|||||
|
2017
Q1 | $1.19M | Buy |
|
|||||
|
2016
Q4 | $930K | Buy |
|
|||||
|
2016
Q3 | $465K | Buy |
|
|||||
|
2016
Q2 | $280K | Buy |
|
|||||
|
2016
Q1 | $172K | Buy |
|
|||||
|
2015
Q4 | $144K | Buy |
|
|||||
|
2015
Q3 | $79K | Sell |
|
|||||
|
2015
Q2 | $166K | Buy |
|
|||||
|
2015
Q1 | $127K | Buy |
|
|||||
|
2014
Q4 | $97K | Sell |
|
|||||
|
2014
Q3 | $207K | Sell |
|
|||||
|
2014
Q2 | $322K | Buy |
|